User account

Primary tabs

Latest Post

ImmUniverse

Type: Article

ImmUniverse in a nutshell - watch and share our brand-new animated clip! Together, we @ImmUniverse_EU will improve diagnostic and therapeutic options for patients living with #ulcerativecolitis...

World IBD Day 2021

Type: Article

This year, for World IBD Day, EFCCA would like to promote the discussion on IBD and wellbeing.

We see often that people with IBD do not really tell their story....

EFCCA General Assembly 2021

Type: Article

Our next EFCCA General Assembly will take place on 29 May 2021. Due to the on-going pandemic we will hold the meeting on-line.

Looking forward to meeting our EFCCA members. More info to...

EFCCA Magazine - 1/2021

Type: Article

We have just published our first issue for 2021 of the EFCCA Magazine. You will find plenty of information about our latest activities, news from our members and other interesting stories from our...

EFCCA Patient Talks: COVID-19 vaccination and IBD

Type: Article

Friday 5 February 2021, 4:30 PM – 5:30 PM CET

As part of the EFCCA Patient Talks series, we organised our latest EFCCA Patient Talk which took place on Friday 5 February...

Projects

HCP Training on Biosimilars

Type: Project

EFCCA has been collaborating with Medscape on a training session about biosimilars and the patients' perspective which...

OPTIMISE Study

Type: Clinical Trial

Is there a better way to optimise disease control for patients with ulcerative colitis? A new study aims to find out

Achieving and maintaining effective control of...

The YELLOWSTONE Program is a series of Phase 3 clinical studies for people with moderately to severely active...

User account

Primary tabs

ImmUniverse

World IBD Day 2021

EFCCA General Assembly 2021

EFCCA Magazine - 1/2021

EFCCA Patient Talks: COVID-19 vaccination and IBD

HCP Training on Biosimilars

OPTIMISE Study

EFCCA Patient Talks

The Impact of Perianal Fistulae on a Crohn’s Disease Patient’s Quality of Life

Yellowstone Program Study